Scientific publications

CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma

Alcázar JL [SP], Miranda D, Unanue A, Novoa E, Alemán S, Madariaga L.
Department of Obstetrics and Gynecology, Clínica Universitaria de Navarra, School of Medicine, University of Navarra, Pamplona, Spain.

Magazine: International Journal of Gynaecology and Obstetrics

Date: Feb 1, 2004

Gynaecology and Obstetrics

Primary cytoreductive surgery is considered as one of the cornerstones in the management of patients with advanced ovarian cancer. Recently, the CA-125 serum marker has been proposed for predicting optimal cytoreduction in advanced epithelial ovarian cancer.

In this study we assessed the role of preoperative CA-125 to predict optimal cytoreduction in patients with advanced ovarian cancer. Data on patients 67 patients (mean age: 57 years old, range 21–85 years) with advanced epithelial ovarian cancer that underwent primary cytoreduction surgery at our institution were reviewed. Optimal cytoreduction was defined as the largest volume tumoral residual disease of less than 1 cm. Optimal cytoreduction was achieved in 32 patients.

CITATION  Int J Gynaecol Obstet. 2004 Feb;84(2):173-4

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra